Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | BMC Cancer | 2022 | 35676659 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Spontaneous DNA Synapsis by Forming Noncanonical Intermolecular Structures. | Polymers (Basel) | 2022 | 35632001 | PubTator, text mining | PubMed |
| The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs. | Cancers (Basel) | 2022 | 35625953 | PubTator, text mining | PubMed |
| OGG1 in Lung-More than Base Excision Repair. | Antioxidants (Basel) | 2022 | 35624797 | PubTator, text mining | PubMed |
| Emerging roles of cystathionine β-synthase in various forms of cancer. | Redox Biol | 2022 | 35618601 | PubTator, text mining | PubMed |
| Association between the genetic variants of base excision repair pathway genes and allergic rhinitis susceptibility in Chinese children. | World Allergy Organ J | 2022 | 35600838 | PubTator, text mining | PubMed |
| Alternative end-joining in BCR gene rearrangements and translocations. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35593472 | PubTator, text mining | PubMed |
| Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2022 | 35578648 | PubTator, text mining | PubMed |
| DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis. | Front Aging Neurosci | 2022 | 35572138 | PubTator, text mining | PubMed |
| Exploiting replication gaps for cancer therapy. | Mol Cell | 2022 | 35568026 | PubTator, text mining | PubMed |
| Resistance to DNA repair inhibitors in cancer. | Mol Oncol | 2022 | 35567571 | PubTator, text mining | PubMed |
| DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders. | Int J Mol Sci | 2022 | 35563044 | PubTator, text mining | PubMed |
| Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment. | Cancer Sci | 2022 | 35534984 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| DNA repair and damage pathways in mesothelioma development and therapy. | Cancer Cell Int | 2022 | 35501851 | PubTator, text mining | PubMed |
| Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy. | J Med Imaging Radiat Oncol | 2022 | 35460184 | PubTator, text mining | PubMed |
| Nanoconjugate Synthesis of Elaeocarpus ganitrus and the Assessment of Its Antimicrobial and Antiproliferative Properties. | Molecules | 2022 | 35458641 | PubTator, text mining | PubMed |
| Impact of Nano- and Micro-Sized Chromium(III) Particles on Cytotoxicity and Gene Expression Profiles Related to Genomic Stability in Human Keratinocytes and Alveolar Epithelial Cells. | Nanomaterials (Basel) | 2022 | 35458002 | PubTator, text mining | PubMed |
| Glucose Increases STAT3 Activation, Promoting Sustained XRCC1 Expression and Increasing DNA Repair. | Int J Mol Sci | 2022 | 35457130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=18